Investor Relations | Financial Information
Capex, Depeciation, R&D
| Unit:Yen millions / Fiscal Year | 2017/3 | 2018/3 | 2019/3 | 2020/3 | 2021/3 |
|---|---|---|---|---|---|
| Investment in facilities
Share of cash flow (%)
|
167,631 72.1 |
178,612 114.8 |
173,592 91.9 |
173,429 94.9 |
212,355 96.7 |
| Depreciation expenses
Share of net sales (%)
|
87,491 7.4 |
92,171 7.2 |
106,631 7.7 |
124,984 9.2 |
140,285 9.5 |
| Cash flow
(Net income + Depreciation expenses)
|
232,590 | 155,634 | 188,836 | 182,764 | 219,625 |
| Research and development expenses
Share of net sales (%)
|
91,254 7.7 |
102,641 8.1 |
115,155 8.3 |
117,489 8.6 |
127,046 8.6 |
